世界の分化型甲状腺がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Differentiated Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1856 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、分化型甲状腺がん治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（放射性ヨード除去、甲状腺刺激ホルモン（THS）抑制、化学療法、標的マルチキナーゼ療法、その他）、用途別市場規模（病院、腫瘍センター、病院薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・分化型甲状腺がん治療の市場動向 ・企業の競争状況、市場シェア ・分化型甲状腺がん治療の種類別市場規模（放射性ヨード除去、甲状腺刺激ホルモン（THS）抑制、化学療法、標的マルチキナーゼ療法、その他） ・分化型甲状腺がん治療の用途別市場規模（病院、腫瘍センター、病院薬局、小売薬局） ・分化型甲状腺がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・分化型甲状腺がん治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・分化型甲状腺がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・分化型甲状腺がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・分化型甲状腺がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Mylan pharmaceuticals、Takeda、Alara Pharmaceutical、Abbott laboratories、Bristol Myers、Teva、Jerome Stevens） ・結論

Differentiated thyroid cancer is divided into papillary and follicular thyroid cancer. These cancer types are called as differentiated cancer since papillary and follicular thyroid cancer differ in their biological behavior and may require distinct therapeutic approach. Differentiated thyroid cancer are most common type of thyroid cancer and most curable among other cancers.

Market Analysis and Insights: Global Differentiated Thyroid Cancer Treatment Market
The global Differentiated Thyroid Cancer Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Differentiated Thyroid Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Differentiated Thyroid Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Differentiated Thyroid Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Differentiated Thyroid Cancer Treatment market.

Global Differentiated Thyroid Cancer Treatment Scope and Market Size
Differentiated Thyroid Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Differentiated Thyroid Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Radioiodine Ablation
Thyroid Stimulating Hormone (THS) Suppression
Chemotherapy
Targeted Multikinase Therapy
Others

Segment by Application
Hospitals
Oncology Canters
Hospital Pharmacies
Retail Pharmacies

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Mylan pharmaceuticals
Takeda
Alara Pharmaceutical
Abbott laboratories
Bristol Myers
Teva
Jerome Stevens

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Differentiated Thyroid Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Radioiodine Ablation
1.2.3 Thyroid Stimulating Hormone (THS) Suppression
1.2.4 Chemotherapy
1.2.5 Targeted Multikinase Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Differentiated Thyroid Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Oncology Canters
1.3.4 Hospital Pharmacies
1.3.5 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Differentiated Thyroid Cancer Treatment Market Perspective (2016-2027)
2.2 Differentiated Thyroid Cancer Treatment Growth Trends by Regions
2.2.1 Differentiated Thyroid Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Differentiated Thyroid Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Differentiated Thyroid Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Differentiated Thyroid Cancer Treatment Industry Dynamic
2.3.1 Differentiated Thyroid Cancer Treatment Market Trends
2.3.2 Differentiated Thyroid Cancer Treatment Market Drivers
2.3.3 Differentiated Thyroid Cancer Treatment Market Challenges
2.3.4 Differentiated Thyroid Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Differentiated Thyroid Cancer Treatment Players by Revenue
3.1.1 Global Top Differentiated Thyroid Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Differentiated Thyroid Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Differentiated Thyroid Cancer Treatment Revenue
3.4 Global Differentiated Thyroid Cancer Treatment Market Concentration Ratio
3.4.1 Global Differentiated Thyroid Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Differentiated Thyroid Cancer Treatment Revenue in 2020
3.5 Differentiated Thyroid Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Differentiated Thyroid Cancer Treatment Product Solution and Service
3.7 Date of Enter into Differentiated Thyroid Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Differentiated Thyroid Cancer Treatment Breakdown Data by Type
4.1 Global Differentiated Thyroid Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Differentiated Thyroid Cancer Treatment Breakdown Data by Application
5.1 Global Differentiated Thyroid Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Differentiated Thyroid Cancer Treatment Market Size (2016-2027)
6.2 North America Differentiated Thyroid Cancer Treatment Market Size by Type
6.2.1 North America Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Differentiated Thyroid Cancer Treatment Market Size by Application
6.3.1 North America Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Differentiated Thyroid Cancer Treatment Market Size by Country
6.4.1 North America Differentiated Thyroid Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Differentiated Thyroid Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Differentiated Thyroid Cancer Treatment Market Size (2016-2027)
7.2 Europe Differentiated Thyroid Cancer Treatment Market Size by Type
7.2.1 Europe Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Differentiated Thyroid Cancer Treatment Market Size by Application
7.3.1 Europe Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Differentiated Thyroid Cancer Treatment Market Size by Country
7.4.1 Europe Differentiated Thyroid Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Differentiated Thyroid Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Differentiated Thyroid Cancer Treatment Market Size (2016-2027)
9.2 Latin America Differentiated Thyroid Cancer Treatment Market Size by Type
9.2.1 Latin America Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Differentiated Thyroid Cancer Treatment Market Size by Application
9.3.1 Latin America Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Differentiated Thyroid Cancer Treatment Market Size by Country
9.4.1 Latin America Differentiated Thyroid Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Differentiated Thyroid Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Mylan pharmaceuticals
11.1.1 Mylan pharmaceuticals Company Details
11.1.2 Mylan pharmaceuticals Business Overview
11.1.3 Mylan pharmaceuticals Differentiated Thyroid Cancer Treatment Introduction
11.1.4 Mylan pharmaceuticals Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021)
11.1.5 Mylan pharmaceuticals Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Differentiated Thyroid Cancer Treatment Introduction
11.2.4 Takeda Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021)
11.2.5 Takeda Recent Development
11.3 Alara Pharmaceutical
11.3.1 Alara Pharmaceutical Company Details
11.3.2 Alara Pharmaceutical Business Overview
11.3.3 Alara Pharmaceutical Differentiated Thyroid Cancer Treatment Introduction
11.3.4 Alara Pharmaceutical Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021)
11.3.5 Alara Pharmaceutical Recent Development
11.4 Abbott laboratories
11.4.1 Abbott laboratories Company Details
11.4.2 Abbott laboratories Business Overview
11.4.3 Abbott laboratories Differentiated Thyroid Cancer Treatment Introduction
11.4.4 Abbott laboratories Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021)
11.4.5 Abbott laboratories Recent Development
11.5 Bristol Myers
11.5.1 Bristol Myers Company Details
11.5.2 Bristol Myers Business Overview
11.5.3 Bristol Myers Differentiated Thyroid Cancer Treatment Introduction
11.5.4 Bristol Myers Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021)
11.5.5 Bristol Myers Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Differentiated Thyroid Cancer Treatment Introduction
11.6.4 Teva Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021)
11.6.5 Teva Recent Development
11.7 Jerome Stevens
11.7.1 Jerome Stevens Company Details
11.7.2 Jerome Stevens Business Overview
11.7.3 Jerome Stevens Differentiated Thyroid Cancer Treatment Introduction
11.7.4 Jerome Stevens Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021)
11.7.5 Jerome Stevens Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Differentiated Thyroid Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Radioiodine Ablation
Table 3. Key Players of Thyroid Stimulating Hormone (THS) Suppression
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Targeted Multikinase Therapy
Table 6. Key Players of Others
Table 7. Global Differentiated Thyroid Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Differentiated Thyroid Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Differentiated Thyroid Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Differentiated Thyroid Cancer Treatment Market Share by Regions (2016-2021)
Table 11. Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Differentiated Thyroid Cancer Treatment Market Share by Regions (2022-2027)
Table 13. Differentiated Thyroid Cancer Treatment Market Trends
Table 14. Differentiated Thyroid Cancer Treatment Market Drivers
Table 15. Differentiated Thyroid Cancer Treatment Market Challenges
Table 16. Differentiated Thyroid Cancer Treatment Market Restraints
Table 17. Global Differentiated Thyroid Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Differentiated Thyroid Cancer Treatment Market Share by Players (2016-2021)
Table 19. Global Top Differentiated Thyroid Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Differentiated Thyroid Cancer Treatment as of 2020)
Table 20. Ranking of Global Top Differentiated Thyroid Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Differentiated Thyroid Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Differentiated Thyroid Cancer Treatment Product Solution and Service
Table 24. Date of Enter into Differentiated Thyroid Cancer Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Differentiated Thyroid Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Differentiated Thyroid Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Differentiated Thyroid Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Differentiated Thyroid Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Differentiated Thyroid Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Differentiated Thyroid Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Differentiated Thyroid Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Differentiated Thyroid Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Mylan pharmaceuticals Company Details
Table 65. Mylan pharmaceuticals Business Overview
Table 66. Mylan pharmaceuticals Differentiated Thyroid Cancer Treatment Product
Table 67. Mylan pharmaceuticals Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021) & (US$ Million)
Table 68. Mylan pharmaceuticals Recent Development
Table 69. Takeda Company Details
Table 70. Takeda Business Overview
Table 71. Takeda Differentiated Thyroid Cancer Treatment Product
Table 72. Takeda Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021) & (US$ Million)
Table 73. Takeda Recent Development
Table 74. Alara Pharmaceutical Company Details
Table 75. Alara Pharmaceutical Business Overview
Table 76. Alara Pharmaceutical Differentiated Thyroid Cancer Treatment Product
Table 77. Alara Pharmaceutical Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021) & (US$ Million)
Table 78. Alara Pharmaceutical Recent Development
Table 79. Abbott laboratories Company Details
Table 80. Abbott laboratories Business Overview
Table 81. Abbott laboratories Differentiated Thyroid Cancer Treatment Product
Table 82. Abbott laboratories Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021) & (US$ Million)
Table 83. Abbott laboratories Recent Development
Table 84. Bristol Myers Company Details
Table 85. Bristol Myers Business Overview
Table 86. Bristol Myers Differentiated Thyroid Cancer Treatment Product
Table 87. Bristol Myers Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021) & (US$ Million)
Table 88. Bristol Myers Recent Development
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Differentiated Thyroid Cancer Treatment Product
Table 92. Teva Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021) & (US$ Million)
Table 93. Teva Recent Development
Table 94. Jerome Stevens Company Details
Table 95. Jerome Stevens Business Overview
Table 96. Jerome Stevens Differentiated Thyroid Cancer Treatment Product
Table 97. Jerome Stevens Revenue in Differentiated Thyroid Cancer Treatment Business (2016-2021) & (US$ Million)
Table 98. Jerome Stevens Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Differentiated Thyroid Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Radioiodine Ablation Features
Figure 3. Thyroid Stimulating Hormone (THS) Suppression Features
Figure 4. Chemotherapy Features
Figure 5. Targeted Multikinase Therapy Features
Figure 6. Others Features
Figure 7. Global Differentiated Thyroid Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Oncology Canters Case Studies
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Differentiated Thyroid Cancer Treatment Report Years Considered
Figure 13. Global Differentiated Thyroid Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Differentiated Thyroid Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Differentiated Thyroid Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Differentiated Thyroid Cancer Treatment Market Share by Regions (2022-2027)
Figure 17. Global Differentiated Thyroid Cancer Treatment Market Share by Players in 2020
Figure 18. Global Top Differentiated Thyroid Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Differentiated Thyroid Cancer Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Differentiated Thyroid Cancer Treatment Revenue in 2020
Figure 20. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Differentiated Thyroid Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Differentiated Thyroid Cancer Treatment Market Share by Type (2016-2027)
Figure 24. North America Differentiated Thyroid Cancer Treatment Market Share by Application (2016-2027)
Figure 25. North America Differentiated Thyroid Cancer Treatment Market Share by Country (2016-2027)
Figure 26. United States Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Differentiated Thyroid Cancer Treatment Market Share by Type (2016-2027)
Figure 30. Europe Differentiated Thyroid Cancer Treatment Market Share by Application (2016-2027)
Figure 31. Europe Differentiated Thyroid Cancer Treatment Market Share by Country (2016-2027)
Figure 32. Germany Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Differentiated Thyroid Cancer Treatment Market Share by Region (2016-2027)
Figure 42. China Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Differentiated Thyroid Cancer Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Differentiated Thyroid Cancer Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Differentiated Thyroid Cancer Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Differentiated Thyroid Cancer Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Differentiated Thyroid Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Mylan pharmaceuticals Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2016-2021)
Figure 62. Takeda Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2016-2021)
Figure 63. Alara Pharmaceutical Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2016-2021)
Figure 64. Abbott laboratories Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2016-2021)
Figure 65. Bristol Myers Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2016-2021)
Figure 66. Teva Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2016-2021)
Figure 67. Jerome Stevens Revenue Growth Rate in Differentiated Thyroid Cancer Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---